Microcosm, a privately held engineering company that has traditionally played in the optical-instruments and imaging-systems markets, this week entered the molecular biology market by launching its BioBright microarray substrates.
While the “very competitive” slide space includes products from vendors like Corning, Schott-Nexterion, Whatman, and Gentel Biosciences, Microcosm believes it has a shot at capturing market share due to the performance of its technology, according to Microcosm CEO Wayne Moore.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.